Glencore downgraded on valuation grounds

UBS downgraded Glencore to “neutral” after a >30% rally in the shares, raising its 12‑month target to 425p (from 410p) but citing only ~11% upside from the current 382p and valuation-driven limits to future returns. The broker cautions that Glencore’s copper leverage is weaker than investors assume—copper is about one‑third of group EBITDA versus 70%+ for some peers—so while higher copper prices should lift EBITDA modestly in 2026, lower copper volumes and broadly flat contributions from coal, zinc and marketing (≈65% of EBITDA) mean limited near‑term earnings upside; UBS expects 2025 EBITDA of ~$13.4bn, net debt above $10bn and scope for roughly $1bn more buybacks funded by Bunge stake sales. With key copper approvals likely in 1H‑2026 but material volume growth pushed into the 2030s, UBS concludes neither near‑term cash returns nor growth are especially compelling.

Analysis

UBS downgraded Glencore PLC to "neutral" while raising its 12‑month price target to 425p (from 410p); with shares at 382p after a >30% six‑month rally UBS sees only ~11% upside and judges valuation now constraining further returns. The broker expects a modest year‑on‑year rise in EBITDA for 2026 driven by higher copper prices but offset by lower copper volumes, and it highlights that copper contributes about one‑third of Glencore’s EBITDA versus ~70%+ for some peers, reducing the company’s leverage to a copper upswing.

Around 65% of group EBITDA comes from coal, zinc and marketing, which UBS forecasts will be broadly flat in 2026 as seaborne thermal and metallurgical coal and zinc face price pressure from returning supply and weak demand; UBS forecasts roughly $13.4bn EBITDA in 2025 with a stronger H2. Net debt is expected to remain above $10bn at end‑2025, and UBS sees scope for ~ $1bn of additional buybacks likely funded by further sales of the Bunge stake, limiting balance‑sheet flexibility for larger returns.

Near‑term growth is muted: key copper projects (MARA, El Pachon) are expected to seek approvals in 1H 2026 with Coroccohuayco possibly late 2026 and first production not until 2028, while material volume growth is pushed into the 2030s. The combination of constrained upside, commodity price risks (coal and zinc), continued elevated net debt and delayed production catalysts underpins UBS’s view that neither near‑term cash returns nor growth are especially compelling for Glencore.

Key Decisions for Investors

• Consider trimming or avoiding new long positions in Glencore given limited ~11% upside to UBS's 425p target and recent >30% rally,
• Rotate toward purer copper exposure if seeking commodity upside; UBS prefers miners with higher copper mix (peers cited with ~70%–80% copper exposure) rather than diversified groups like Glencore,
• If maintaining exposure, monitor catalysts and risk triggers closely: approvals for MARA and El Pachon in 1H 2026, Coroccohuayco timing, quarterly production/volume updates, commodity price trends for copper/coal/zinc, and net debt trajectory including proceeds from Bunge stake sales,
• Manage downside with position sizing or hedges to protect against weaker coal and zinc prices and execution delays given UBS expects flat contribution from those segments and net debt above $10bn at end‑2025